BridgeBio Pharma (BBIO) Retained Earnings (2017 - 2026)
BridgeBio Pharma's (BBIO) quarterly Retained Earnings came in at -$8000.0 in Q1 2026, down 166.67% quarter-over-quarter from $12000.0 in Q4 2025.
BridgeBio Pharma (BBIO) Retained Earnings (2017 - 2026) Analysis & Trends
BridgeBio Pharma has disclosed Retained Earnings across 10 years of filings, most recently posting -$8000.0 for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$8000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$8000.0 (changed N/A YoY), and the FY2025 annual result was $12000.0, up 50.0% from the prior year.
- Retained Earnings came in at -$8000.0 for Q1 2026 at BridgeBio Pharma, down from $12000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $34000.0 in Q3 2023 to a low of -$3.6 billion in Q3 2025.
- The 5-year median for Retained Earnings is -$377500.0 (2022), against an average of -$1.0 billion.
- Across the five-year window, Retained Earnings soared 109.45% in 2023 and slumped 72566720.0% in 2025, its largest moves.
- BridgeBio Pharma's Retained Earnings stood at -$328000.0 in 2022, then soared by 109.45% to $31000.0 in 2023, then slumped by 74.19% to $8000.0 in 2024, then surged by 50.0% to $12000.0 in 2025, then plunged by 166.67% to -$8000.0 in 2026.
- The last three Retained Earnings figures came in at -$8000.0 (Q1 2026), $12000.0 (Q4 2025), and -$3.6 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | BridgeBio Pharma | 12.90 Bn | 11.97 Bn | 184.58 Mn | -8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | -3.63 Bn |
| Jun 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | -2.67 Bn |
| Mar 31, 2024 | -2.60 Bn |
| Dec 31, 2023 | 31,000.00 |
| Sep 30, 2023 | 34,000.00 |
| Jun 30, 2023 | -2.22 Bn |
| Mar 31, 2023 | -2.06 Bn |
| Dec 31, 2022 | -328,000.00 |
| Sep 30, 2022 | -1.78 Bn |
| Jun 30, 2022 | -427,000.00 |
| Mar 31, 2022 | -1.63 Bn |
| Dec 31, 2021 | -132,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | -1.13 Bn |
| Mar 31, 2021 | -57,000.00 |